Genix Pharmaceuticals Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GENPF research report →
Companywww.genixpharm.com
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. The company develops Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Renochlor, a dietary supplement to aid in the restoration of kidney health and kidney function; and Sucanon, an insulin sensitizer that lowers blood sugar by increasing the muscle, fat, and liver's sensitivity to insulin. It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and drops.
- CEO
- Sina Salehi Pirooz
- IPO
- 2020
- Employees
- 4,000
- HQ
- Vancouver, BC, CA
Price Chart
Valuation
- Market Cap
- $863.26K
- P/E
- -4.63
- P/S
- 0.00
- P/B
- -0.81
- EV/EBITDA
- -19.06
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 18.11%
- ROIC
- 15.05%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $-335,009 · -357.69%
- EPS
- $-0.01 · -366.67%
- Op Income
- $-153,262.3
- FCF YoY
- 33.78%
Performance & Tape
- 52W High
- $0.04
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.02
- Beta
- 0.47
- Avg Volume
- 10.93K
Get TickerSpark's AI analysis on GENPF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GENPF Coverage
We haven't published any research on GENPF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GENPF Report →